Article
Cancer stem cells: A product of clonal evolution?
International journal of cancer - 1 Mar 2017
van Niekerk Gustav, Davids Lester M, Hattingh Suzèl M, Engelbrecht Anna-Mart
Abstract excerpt
The cancer stem cell (CSC) model has emerged as a prominent paradigm for explaining tumour heterogeneity. CSCs in tumour recurrence and drug resistance have also been implicated in a number of studies. In fact, CSCs are often identified by their expression of drug-efflux proteins which are also highly expressed in normal stem cells. Similarly, pro-survival or proliferation signalling often exhibited by stem cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
